Cardiac Implant ID-er; CVD Gaps by County; Gov. Asked to Act on Cardiology Lawsuit

The FDA cleared BridgeSource’s SmartRead system for easy identification of cardiac implants by brand. (Mass Device)

LDL cholesterol has noticeably improved in young people without atherosclerotic cardiovascular disease (CVD), researchers gleaned from National Health and Nutrition Examination Survey data from 1999 to 2023. (Circulation)

Despite the sustained progress in CVD survival in the U.S., there is still much county-by-county variation — which can be bigger than the gaps between states. (Journal of the American College of Cardiology)

European cardiovascular groups released guidance on how clinicians can advise their patients regarding the harms of extreme heat on heart health. (European Heart Journal)

Researchers made a case for the new U.S. Candidate Risk Score facilitating better prioritization of the sickest adult heart transplant candidates, showing a potential of reduced waitlist deaths without increasing distance for grafts to travel based on registry data modeling. (JAMA)

For donor heart recovery, investigators described pediatric-specific rapid recovery with the extended ultra-oxygenated preservation technique. (New England Journal of Medicine)

In ATTRibute-CM, early serum transthyretin increases were associated with later NT-proBNP changes, and putting the two together yielded a ratio predictive of hard outcomes. (JACC: Heart Failure)

Cytokinetics announced additional cardiopulmonary exercise testing data from the ACACIA-HCM trial supported aficamten (Myqorzo) use in nonobstructive hypertrophic cardiomyopathy.

Popular artificial intelligence chatbots were often mistaken about whether a blood pressure (BP) monitor on the market is validated or not, according to research highlighted by the American Heart Association.

A meta-analysis favored intensive BP lowering in people with hypertension, even if they have chronic kidney disease. (JAMA Cardiology)

Real-world records linked pregnancy complications to higher risks of subsequent CVD, type 2 diabetes, high BP, and chronic kidney disease. (BMJ Medicine)

New York Gov. Kathy Hochul (D) should step in to ensure that 50,000 cardiology patients don’t lose access to their doctors amid litigation between Ellis Medicine and St. Peter’s Healthcare over noncompete agreements, said state Sen. James Tedisco.

Johnson & Johnson said that Shockwave peripheral intravascular lithotripsy therapy continued to show safety and effectiveness 24 months into the DISRUPT BTK II postmarket study in calcified below-the-knee lesions.

The FDA raised concerns of fatal arrhythmia linked to the experimental schizophrenia drug evenamide, for which a clinical hold is still in place. (Reuters)

Statin users appear to be protected from glaucoma worsening to require surgery, a global observational study found. (British Journal of Ophthalmology)